| Correlogic Systems Obtains CE Mark for OvaCheck® |  |  |  |
| Saturday, 12 June 2010 | |
| "Correlogic Systems, Inc. announced today that OvaCheck, the company's blood test for the detection of epithelial ovarian cancer, has fulfilled European Union regulatory requirements (CE marking) for distribution and sale of the test. The path is now cleared for the test to be made available to patients in Europe through their physicians...." |
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.